Racura Oncology Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 4, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	417	204	311	200	311	527
Market Cap Growth	93.04%	-34.32%	55.59%	-35.78%	-41.00%	546.75%
Enterprise Value	404	185	297	173	274	522
Last Close Price	2.30	1.18	1.82	1.23	1.95	3.67
PS Ratio	69.09	33.78	64.27	63.73	439.48	1360.92
PB Ratio	26.07	12.75	16.97	7.84	8.62	38.42
P/TBV Ratio	30.97	15.14	20.05	8.92	9.50	52.37
EV/Sales Ratio	66.83	30.68	61.43	55.32	387.06	1346.52
Asset Turnover	0.32	0.32	0.21	0.10	0.03	0.04
Quick Ratio	9.42	9.42	9.26	20.16	23.71	18.07
Current Ratio	10.29	10.29	9.32	20.44	24.10	20.24
Return on Equity (ROE)	-27.89%	-27.89%	-63.10%	-32.22%	-44.96%	-65.32%
Return on Assets (ROA)	-15.63%	-15.63%	-36.41%	-20.41%	-27.05%	-39.39%
Return on Capital Employed (ROCE)	-29.40%	-29.40%	-74.40%	-41.10%	-31.00%	-46.30%
Earnings Yield	-1.15%	-2.34%	-4.45%	-4.97%	-3.60%	-1.20%
Buyback Yield / Dilution	-4.81%	-4.81%	-2.35%	-4.83%	-17.06%	-22.86%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.